GRANT CALENDAR 2019 - SINGHEALTH RESEARCH
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Grant Calendar 2019
KEEPING THE CULTURE ALIVE: RESEARCHERS BEHIND THE SCENE
A Clinical Research Coordinator (CRC) develops, implements, and coordinates research and administrative procedures
What does a Clinical
for the successful management of clinical trials. In SingHealth, CRCs across various hospitals and institutions are assigned
to manage an average of six to eight trials. Before a study commences, CRCs have to train the study team and prepare
Research Coordinator do? all source documents to ensure smooth execution of the study. We speak to Ms Yvonne Chan who works with clinicians
to coordinate NCCS Phase 1 oncology trials in lung cancer, pancreatic cancer and a biomarker-selected trial in advanced
solid tumours.
A Day In The life Of A Clinical Research Coordinator (CRC) with Ms Yvonne Chan, NCCS
Patient Visits Multi-tasking
It is 9am and the first patient research Yvonne heads outside to
volunteer, Mr. John, has arrived at the the waiting area to collect
waiting area at Clinic C for his scheduled blood specimens and
research consultation. Today is his first day reimbursement requests
enrolling in a Phase 1 industry-sponsored from another trial applicant.
drug trial. Yvonne has scheduled all Clutching samples and
trial-related procedures and discussed documents belonging to
study protocols and the logistics involved separate clinical trials, she
in the trial. Her role requires extensive heads back in to transcribe
coordination amongst different parties, the data into online platforms.
from scheduling patient lab work and With multiple patients/trials,
clinical tests, collecting and processing tracking everything takes a lot
blood/urine specimens, to dispensing of time and requires Yvonne’s
study medication. close attention to detail.
Working In Phase I Units Bridge Between Patients & Research Team Back To Office
For CRCs working in Phase I units, the whole day could Yvonne has five patients to attend to today. Her After attending to the
be spent with subject(s) if it’s their first day of dosing as third subject visit has already arrived at the clinic patients, Yvonne returns
the process involves a lot of blood taking (for research and is asking her various questions regarding his to her office to focus on
samples) and processes. Whenever a trial patient visit. Yvonne is often the first contact for patient administrative matters
returns for consultation, Yvonne will attend the visit to volunteers and their families for these clinical trials. such as paperwork from
assist investigators and has to stay tuned to any little the subject visits earlier
symptom or issue that is going on, and ensure proper in the day, answering
documentation of the entire clinical study. sponsors’ queries,
preparing patient visits,
ensuring she has the
necessary lab supplies,
source documents and so
forth. CRCs also hold a key
responsibility in ensuring
that serious and non-
serious adverse events are
documented and reported
in a timely manner.
Medical laboratory scientists collect all types of patient samples for analyses that provide evidence-based diagnoses to
What does a Medical inform medical decisions in the hospital daily. As a Senior Medical Laboratory Scientist, Wing Yue wears two hats as he
Laboratory Scientist do? works in SGH’s Department of Plastic, Reconstructive & Aesthetic Surgery to harness adipose-derived stem cells to support
regenerative purposes, and as a research scientist with his own research projects.
A Day In The life Of A Medical Laboratory Scientist (MLS) with Mr Wing Yue, Ph.D.
Preparing The Lab Bench Getting Technical
Wing Yue reaches the laboratory by 9am and his day usually starts off with checking emails and Wing Yue spends most of his days at Bench 22 in the SGH Research Lab at Level 9 of Academia
responding to queries. He will then check on the progress of laboratory tests and research in order where he also performs clinical duties for SGH’s Skin Bank Unit, focused in the area of cultured
to prepare for the day’s work ahead. If there are uncompleted assays from the day before or new epidermal autografts (CEA) used in the treatment of burn injuries at SGH.
ones to start on, he will set up the bench with all necessary equipment and solutions required.
Multi-tasking And Various Roles Getting Out & Beyond The Lab The Work Never Ends
Wing Yue doesn’t spend Due to the nature of his job,
all his time in the lab. As a Wing Yue frequently works late.
research scientist himself, The role of medical laboratory
he is in the midst of applying professionals extends beyond
for grant funding for bench work. He shared that
research focused in creating the field has steep learning
small diameter blood vessel curves and it is crucial to
grafts to overcome the main constantly upgrade technical
drawbacks of autografts. As skills by attending workshops
the field constantly evolves and seminars on the latest
Wing Yue is concurrently working on 5 different and changes, there are technologies available. As they
projects. After lunch, he begins harvesting cells many new projects within collect and analyse results
from fat tissues derived from animal specimens the department in the field from daily experiments, they
to characterise them for further analysis. As the of material science and must develop the necessary
experiments run, he has to sort out procurement tissue engineering that is skills to write manuscripts and
processes as well. ripe for invention. give poster presentations.Clinical research biostatisticians design, conduct and analyse data generated from clinical studies and trials
What does a Clinical conducted within our AMC. We speak to Dr Tan Sze Huey, Senior Biostatistician and Head, Biostatistics & Quantitative
Epidemiology (BQE), who shares that the role is always project-based, involves meetings with collaborators/Pls, as
Research Biostatistician do? well as focusing on independent work tasks. Biostatisticians are members of a larger study team with one primary
focus: finding an answer to the clinical question that poses a problem in the medical landscape.
Interview with Dr Tan Sze Huey, Biostatistics & Quantitative Epidemiology (BQE), SingHealth
Getting Technical Conduct Phase Analysis Phase
The 2nd phase is where she helps doctors Analysis utilise the most amount of time. The first step
monitor the study throughout its conduct; is reviewing the data set to check whether the data is
how the recruitment rate is and if they are “clean” before they can begin analysis. Data collection
hitting targets. As a lot of projects are grant- is subject to human errors that potentially negatively
based, she will closely monitors if they are able impact analyses. Statistical software is used to
to fulfill what has been set out in a reasonable code, program and write functions to carry out data
amount of time. Biostatisticians work closely analysis. This phase requires time for meetings as well
with CRCs who capture the routine data. to address queries from the data collected.
Beyond The Statistics Different Roles
Every clinical study/trial begins with 70% of Dr Tan’s time is spent at her A biostatistician role extends beyond crunching numbers.
designing the study geared towards desk focusing on independent work They play an active role in discussing and deciding
answering the clinical question task - the problem itself, doing study effectiveness of the trials, logistics and other implications
of interest. This phase is crucial as design and analysis work. She shared that present throughout the trial. She gets busy during
achieving research objectives and that now is a busy time for them as major conferences as well, reviewing pending abstract
obtaining the correct variables they are receiving grant proposal and poster submissions. She will provide comments and
require properly designed trials. Dr rebuttals from funding agencies where review the interpretation of results from their data to
Tan will allocate time for meetings/ she has to address questions received ensure that it is accurate and communicates what the
discussions with clinicians and other on study design, data variables being data is really saying. After all, they are the ones who know
study team members. measured and so forth. the data and interpretation of results best!
BEHIND THE SCENES OF RESEARCH ADMINISTRATION
Q How did you first get into healthcare?
Interview with
Ms. Enny Kiesworo A I was trained in Pharmacy, and subsequently Hospital Administration followed
by Health Policy and Finance, so getting into healthcare is a natural choice for
(COO, Research, SingHealth) my job.
Q What do you love most about your job?
As Chief Operating Officer, Research, SingHealth, Ms. Enny Kiesworo is integral to A I love meeting people from different backgrounds and expertise, exploring with
the development of the SingHealth Duke-NUS Academic Medical Centre (AMC) them new and innovative ways of doing things which will make us more
into a world class institution that is internationally recognised for its exceptional competitive and strategic. I am lucky in the sense that I always feel energised at
clinical services, pioneering research and forward-thinking education. work as I work and interact with a diverse group of passionate colleagues and
collaborators, discussing on opportunities and cutting-edge research.
A dynamic leader, Ms. Kiesworo oversees the function and general administration
and operations of all stakeholders under Group Research. Her areas of oversight
include policy and governance, finance, research facilities and core platforms, Q What are some of the challenges you face as COO of Group Research?
communications, technology transfer and commercialisations, as well as research
compliance. In Research, things are constantly changing and Enny is always at A As research involves exploring new things and breaking new ground, the
the forefront leading and adapting the Group to ensure that we are proactive in challenges are different for different initiatives. These usually fall into a few
supporting the growing and evolving research needs of our AMC. common themes like research funding landscape, changing and evolving
research regulations and IT security. Oftentimes, operational processes require
time, effort and resources to meet changing requirements.
Q Tell us about a typical working day for you.
A My days are normally filled with meetings, phone conversations and discussions Q What would you hope to accomplish in the next 3 years for the AMC
with researchers and their teams, support offices and collaborators on various research community?
research matters. We discuss a wide range of topics like funding opportunities,
research support infrastructures, compliance efforts, research enablers and A Human capital is the most important asset of any organization, especially if
management of research outcomes. As a research community, we are always we aspire to be the leading AMC in the region. I hope as a group, we are able
exploring ways on how we can further enhance research in our AMC through to identify and groom sufficient research talents and their support teams,
better management of resources and joint efforts amongst different offices inclusive of competent research administrators, so that we can build a solid and
within the AMC and external collaborators. productive research ecosystem in SingHealth.
SINGHEALTH DUKE-NUS AMC – SINGAPORE’S LEADING ACADEMIC MEDICAL CENTRE
As part of an Academic Medical Centre with Duke-NUS Medical School, SingHealth has a thriving research innovation community. Research and innovation to improve delivery of care go hand-in-
hand, and SingHealth’s researchers are inspired by the many types of medical challenges they face daily. Research often leads to the development of inventions, with both significant clinical impact
and commercialisation potential. These inventions are suitable for technology transfer, i.e. the translation of research findings into commercial products for patient care. Typically, this is achieved by
licensing or spin outs.
SingHealth Intellectual Property (SHIP)
Advancing Research Innovations
Invention assessment to Patent filing and Identifying industry Negotiating license Post-deal management Support for SingHealth’s
determine patent ability maintenance partners and marketing of agreements IP-related issues (training,
and commercial potential technologies translational funding etc.)
SingHealth’s research innovators have developed innovations across a diverse range of fields and technology types, reflecting the breadth of research at SingHealth. To discuss how SHIP can support with the IP aspects of your research
outputs, please contact us at ship@singhealth.com.sg.TIPS ON RESEARCH ADVOCACY
Healthcare and medical researchers, basic scientists and clinician scientists alike, aim to translate their discoveries into financially viable solutions that
improve patient care. With rising challenges in the healthcare industry, funding and buy-in to your research is more crucial than ever. If you are gearing
up for a pitch, we have compiled some simple steps that you can take to extend the reach and impact of your research presentation.
Know the significant difference in Focus on the goal: What is the Develop an elevator pitch before Fundamentals to building
content between a scientific talk problem and what is your unique the presentation a narrative
and a pitch idea that solves this problem?
A successful pitch doesn’t just focus on the You shouldn’t be trying to validate your Your target is brevity and coherence; imagine A strong narrative can effectively communicate
science - you should present integrated research results in a pitch. Your goal is primarily you have 30 seconds to a minute to give your scientific information. First, know your
information beyond your disciplinary span; cover to help reviewers determine that your research an oral summary without any supporting audience and create digestible slides/ titles that
equally important financial, regulatory, marketing is a potentially attractive idea (do provide documents - establish the minimum speak directly to your audience. Second, convey
and other concerns in your presentation to representative data demonstrating progress!) essential information, be wary of exceeding through words and images how your idea
grab the attention of your audience. Aim at the and secure that follow-up meeting! Simply put, the time limit and build a narrative. Oh, and transforms into actionable steps that solves a real
intelligent layperson and make them interested you don’t need to provide a lengthy detailed make sure you practice, practice, practice! scientific problem, show benefits and addresses
enough to ask questions to find out more. explanation of why/how this works but you do market need. Lastly, get personal. Introduce your
need to convince them that it is important. team and why your skills make your research
stand out to accomplish your goals.
Make sure you don’t compromise a patent positive by disclosing your innovation. Speak to SHIP if you need guidance!
USEFUL CONTACTS
Duke-NUS Centres Core Platforms, Strategic Programmes & Supporting Centres
Centre for Ageing Research and Education (CARE) Advanced Molecular Pathology Laboratory (AMPL)
General enquiries care@duke-nus.edu.sg General enquiries ampl@singhealth.com.sg
Centre for Clinician-Scientist Development (CCSD) SingHealth Advanced Bio-imaging
Ms Farn Choy Hoong fion.farn@duke-nus.edu.sg General enquiries bioimaging@singhealth.com.sg
Centre for Computational Biology (CCB) SingHealth Biostatistics and Quantitative Epidemiology (BQE)
General enquiries Dr Tan Sze Huey tan.sze.huey@singhealth.com.sg
Centre for Quantitative Medicine (CQM) SingHealth Clinical Pharmacology
Ms Katherine Wang katherine.wang@duke-nus.edu.sg General enquiries clin.pharm@singhealth.com.sg
Centre of Regulatory Excellence (CoRE) SingHealth Clinical Trials Coordinating Centre (CTCC)
General enquiries gmsbx103@nus.edu.sg General enquiries ctcc@singhealth.com.sg
Lien Centre for Palliative Care (LCPC) SingHealth Experimental Medicine Centre (SEMC) and National Large Animal Research Facility (NLARF)
General enquiries lcpc@duke-nus.edu.sg General enquires 6576 7041 shs.semc@singhealth.com.sg
SingHealth Flow Cytometry
Ethics & Compliance General enquiries flow@singhealth.com.sg
Centralised Institutional Review Board (CIRB) SingHealth Health Services Research Centre (HSRC)
General enquiries 6323 7515 irb@singhealth.com.sg General enquiries hsr@singhealth.com.sg
Institutional Animal Care and Use Committee (IACUC) SingHealth Investigational Medicine Unit (IMU)
Ms Serene Lok 6576 7015 General enquiries imu@singhealth.com.sg
iacuc@singhealth.com.sg
Mr Avon Koh 6576 7030
SingHealth Medical Technology Office (MTO)
iSHaRe Support 6576 7020 ishare@singhealth.com.sg General enquiries mto@singhealth.com.sg
Office of Research Integrity and Compliance (ORIC) SingHealth Tissue Repository (STR)
General enquiries 6377 1219 oric@singhealth.com.sg General enquiries tissue.repository@singhealth.com.sg
Institutional Biosafety Committee (IBC)
Ms Cindy Goh 6377 8533 cindy.goh.j.e@singhealth.com.sg Joint Research Institutes
Health Services Research Institute (HSRI)
Grants Administration Ms Charis Ng ng.hwee.fang@singhealth.com.sg
Dr Si-Hoe San Ling 6576 7012 si.hoe.san.ling@singhealth.com.sg
Ms Iris Soh 6576 7014 iris.soh.s.j@singhealth.com.sg Infectious Diseases Research Institute (IDRI)
Ms Simi Issac 66015385 simi.issac@duke-nus.edu.sg
Research Collaboration National Heart Research Institute of Singapore (NHRIS)
Ms Fayce Lau 6576 7016 fayce.lau.w.h@singhealth.com.sg NHRIS Enquiry asknhris@nhcs.com.sg
Dr Isaac Chua 6576 7017 isaac.chua.r.j@singhealth.com.sg
SingHealth Duke-NUS Institute of Precision Medicine (PRISM)
General enquiries prism@singhealth.com.sg
Research Operations
Ms Regina Chan 6576 7027 regina.chan.y.y@singhealth.com.sg Translational Immunology Institute (TII)
Ms Lakshmi Ramakrishna lakshmi.ramakrishna@singhealth.com.sg
Technology Transfer Office (TTO) & Technology Commercialisation
Joint Research Institutes*
There are two other Joint Research Institutes, National Cancer Research Institute Singapore (NCRIS) and National Neuroscience
SingHealth Intellectual Property (SHIP)
Research Institute of Singapore (NNRIS)
Dr Sharron Bennett 6576 7019 sharron.bennett@singhealth.com.sg
Duke-NUS Centre for Technology and Development (CTeD)
General Enquires 6516 7266 cted@duke-nus.edu.sg
List of SingHealth Duke-NUS AMC Core Equipment
Joint Centre for Technology & Development (J-CTeD)* https://research.singhealth.com.sg/PDF/CorePlatformEquipment/SingHealth%20Core%20
J-CTeD is an AMC centre jointly run by SHIP and CTeD to facilitate technology spin-outs Platforms%20Equipment%20-%20201710OCT%20-%20PUBLISH.pdfEligibility Criteria
Citizenship Research Focus Investigator's Research Commitment/ Affiliation
Opening Closing Funding
Award Amount (Years, unless Singaporean (S), Individual (I),
PhD
Non-PhD
Month(s) Month(s) otherwise stated) MD, MBBS, BDS (Scientists,
Permanent Resident (PR), Cross-Institution collaboration (Healthcare Professionals, Specific Requirements
(SMC-registered) Healthcare Professionals,
Foreigner (F) (C-Inst), Industry collaboration Bio-statisticians and others)
Bio-statisticians and others)
NATIONAL
A*STAR Advanced Manufacturing and Engineering (AME) Domain
≤$750K (AME IRG)
• Individual Research Grant (AME-IRG) Jul Sep 3 S, PR, F I √ √
≤$300K (AME YIRG)
• Young Individual Research Grant (AME-YIRG)
A*STAR Advanced Manufacturing and Engineering (AME) Domain
Year-round Realistic quantum corresponding to scope of work 3-5 S, PR, F I √ √ √
A*STAR
• Programmatic Funds
A*STAR
Year-round Realistic quantum corresponding to scope of work Realistic period S, PR, F I, Industry collaboration √ √ √
• Industry Alignment Fund - Industry Collaboration Projects (IAF-ICP)
Should be able to attract
A*STAR
Year-round Realistic quantum corresponding to scope of work industry funding within S, PR, F I √ √ √
• Industry Alignment Fund - Pre-positioning (IAF-PP)
3 - 5 years
BMRC Therapeutics Development Review (TDR) Grant Call Feb Apr ≤S$250K 2 S, PR, F I √ √ √
MOH National Innovation Challenge (NIC) on Active and Confident Ageing Grants Sep Oct ≤80% of approved qualifying costs of realistic quantum 3 S, PR, F I √ √ √
MOH Traditional Chinese Medicine Research Grant (TCMRG) Jan Mar ≤$750K 3 S, PR, F I √ √ √
NMRC Clinician Scientist (CS)
≤$1.5M (CS-IRG) 3 (CS-IRG)
• Individual Research Grant (CS-IRG) May & Nov May & Nov S, PR, F I √ √3
≤$200K (CS-IRG-NIG) 2 (CS-IRG-NIG)
• New Investigator Grant (CS-IRG-NIG)
NMRC Clinician Scientist Award (CSA)
Research grant support (≤$675K [INV] or ≤$1.75M [SI]) 3 (INV) ≥0.5 FTE in research & regular-rank
• Investigator (CSA-INV) May & Nov May & Nov S, PR I √2 √3
+ Salary support 1 5 (SI) faculty/academic appointment at an AMC upon award
• Senior Investigator (CSA-SI)
Commensurate with
NMRC Clinician Scientist/ Clinician Investigator Salary Support Programme (CS/CISSP) May & Nov May & Nov Salary support 1 (≤$300K p.a.) S, PR I √ 0.1 - 0.6 FTE in research
existing active grant life
Realistic quantum corresponding to scope of work
NMRC Clinical Trial Grant (CTG) Year-round (ICT) Minimum leverage ratio is 0.7 : 0.3 (Industry : NMRC 5 S, PR, F Industry collaboration √
• CTG - Industry Collaborative Trials (CTG-ICT) funding) (ICT)
• CTG - Investigator-Initiated Trials (CTG-IIT)
May & Nov (IIT) May & Nov (IIT) ≤$1.5M (IIT) 3 S, PR, F Industry collaboration √
NMRC Health Services Research (HSR)
MOH/ NMRC
Realistic quantum corresponding to scope of work (HSRG) Realistic period (HSRG) √
• Health Services Research Grant (HSRG) May & Nov May & Nov S, PR, F I √ √
≤$100K (HSRG-NIG) 2 (HSRG-NIG) (min. Master’s degree)
• New Investigator Grant (HSRG-NIG)
NMRC Open Fund (OF)
≤$1.5M (OF-IRG) 5 (OF-IRG)
• Individual Research Grant (OF-IRG) May & Nov May & Nov S, PR, F I √ √ √4
≤$300K (OF-YIRG) 3 (OF-YIRG)
• Young Individual Research Grant (OF-YIRG)
NMRC Open Fund (OF)
May Jun ≤$25M 5 S, PR, F I, C-Inst encouraged √ √ √4
• Large Collaborative Grant (OF-LCG)
Research grant support (≤$5M) (Grant support will be
≥0.75 FTE in research in Singapore & regular-rank
NMRC Singapore Translational Research Investigator Award (STaR) May & Nov May & Nov adjusted accordingly for award renewal) 5 S, PR, F I √2 √3
faculty/academic appointment at an AMC upon award
+ Salary support (≤$600K p.a.)
√2
Research grant support (≤$375K) ≥0.5 FTE in research & regular-rank faculty/academic
NMRC Transition Award (TA) May & Nov May & Nov 3 S, PR I (must have had scientific √3
+ Salary support 1 appointment at an AMC upon award
training at MSc/PhD level)
2 (local/overseas
≤$800K (inclusive of salary support & tuition fees; Bond duration
attachment)
NMRC Research Training Fellowship May & Nov May & Nov quantum varies for local/overseas part/full-time research S, PR I √ √ √ 0.5 - 5 years (local attachment/MSc/PhD)
2 - 3 (MSc)
attachment/MSc/PhD) 1 - 7 years (overseas attachment/MSc/PhD)
4 (PhD)
NMRC & NHIC Research grant support (≤$100K)
May & Nov May & Nov 2 S, PR I √
• Clinician Innovator Award (CIA) + Salary support 1
NMRC-NUS Scholarship (inclusive of tuition fees, research fee & Bond duration
Jan Mar 2 S, PR I √
• Master of Clinical Investigation (MCI) Programme potentially other fund) 2.5 years
NHIC Innovation to Develop (I2D) Year-round ≤$250K (I2D) 1 S, PR, F I √ √ √
NHIC Innovation to Industry (I2I) Year-round ≤$250K (I2I) 1 S, PR, F I √ √ √
NHIC
Combination of 3 schemes
SMART-NHIC-ESG • SMART Innovation (≤$250K)
Year-round ≥1 S, PR, F I √ √ √
• Innovation to Startup (I2Start) Pathway • NHIC-I2D (≤$250K)
• ESG Startup SG Tech POC/POV (≤$750K)
I, C-Inst & Industry
NRF Central Gap Fund Year-round >$750K 2 S, PR, F √ √ √
collaboration encouraged
NRF Competitive Research Programme (CRP) Mar & Aug Apr & Oct Realistic quantum corresponding to scope of work 5 S, PR, F I √ √ √
NRF
NRF Fellowship Jan Mar Research grant support (≤$3M) 5 S, PR, F I √
Participation is by nomination through the host university. Researchers holding joint
NRF Investigatorship Feb May Research grant support (≤$3M) 5 S, PR, F I
appointment with local university and/or full-time faculty are eligible for nomination.
CLUSTER
PI must be Duke-NUS Year 3 medical student.
Duke-NUS Medical Student Fellowship (Duke-NUS MSF) May Jun ≤$10K 10 months S, PR, F I
Research Mentor must be from SingHealth Duke-NUS ACP & an approved Duke-NUS Research Mentor/Co-Mentor
Adjunct/regular-rank appointment of Assistant Professor level
Khoo Bridge Funding Programme May & Nov Jun & Jan ≤$125K 1 S, PR, F I √ √
and above in Duke-NUS upon application
≥0.3 FTE in research & adjunct/regular-rank
Khoo Mentored Research Award (KMRA) Year-round ≤$200K 2 S, PR, F I √ √
appointment in Duke-NUS upon award
Khoo Pilot Award (KPA) Year-round ≤$30K 1 S, PR, F I √ √ Adjunct/regular-rank appointment in Duke-NUS upon award
Duke-NUS
Adjunct/regular-rank appointment
Khoo Pilot Award - Collaborative (KPA-Collaborative) Jun Aug ≤$60K 2 S, PR, F C-Inst √ √
in Duke-NUS upon application
PI must have accepted a postdoctoral research position with
Duke-NUS or their Mentor’s institution based in Singapore
Khoo Postdoctoral Fellowship Award (KPFA) Jan Mar ≤$150K 2 S, PR, F I √ √
upon application. Mentor must hold adjunct/regular-rank
appointment in Duke-NUS
Duke (Durham) and Duke-NUS ≤USD $100K (Duke PI) Holders of adjunct/regular-rank appointments in Duke-NUS
Mar May 1 S, PR, F C-Inst √ √ √
• Research Collaborations Pilot Projects Programme ≤SGD $100K (Duke-NUS PI) may apply as Duke-NUS PI
St. Baldrick’s Foundation and Duke-NUS
Jun Jul ≤$50K 1 S, PR, F I √ √ √
• Childhood Cancer Research Grant
Academic Clinical Programme Funding - Research Support (ACP)
• Nurturing Clinician Scientist Scheme (NCSS)
≥0.2 FTE in research.
3 categories
Mar & Aug Apr & Sep ≤$225K 3 S, PR, F I √ √ PI is encouraged to enroll into the Individual Development
- Clinician Scientist (CS)
Plan/Khoo Scholars Programme upon award
- Clinician-Investigator (CIV)
- Clinician-Innovator (CIN)
AM Research Grant Call
≤$50K (Start-up)
• Start-up
Aug Sep ≤$150K (Transition Project) 2 S, PR, F I √ √ √
SINGHEALTH ⁵
• Transition Project
≤$165K (PRISM), ≤$65K (Health Outcomes)
• Special Category (PRISM, Health Outcomes)
AM and NHIC
Jun Jul ≤$100K 1 S, PR, F I √ √ √
• Joint MedTech Grant Call
Collaborative Solutions Targeting Antimicrobial Resistance Threats in Health
System (CoSTAR-HS) Jul Aug ≤$50K 1 S, PR, F C-Inst √ √ √
• Antimicrobial Resistance (AMR) Research Grant
Health Services Research and Analytical Technologies for SingHealth (HEARTS) May Jun HSR and data science resources support 1 S, PR, F C-Inst √ √ √ Open to SingHealth and Duke-NUS PIs
Population-based, Unified, Learning System for Enhanced and Sustainable Health
Grant Call (PULSES) √
Nov Dec ≤$50K 1 S, PR, F I √ √
• Seed Funding (min. Master’s degree)
• Bridging Grant
GENERAL
≤$500K (Level 1)
AI Singapore Research Grant Call Mar Apr 3 S, PR, F I, C-Inst √ √ √
≤$1M (Level 2)
Bayer - Grants4Indications May Jun Realistic quantum corresponding to scope of work 2 S, PR, F I √ √ √
Salary support for awardee (≤$8K/mth) +
ExxonMobil-NUS Research Fellowship Mar & Sep Apr & Oct 0.5 - 1 S, PR I √ ≥0.6 FTE in research
Research consumables for mentor ($20K)
Ferring Singapore Innovation Grant Call
• Exploratory/Discovery grants Jul Aug $50K to $250K 1 S, PR, F I √ √ √
• Clinical research grants
Human Frontier Science Program (HFSP) - Postdoctoral Fellowship Fellowship
• Long-Term Fellowships (LTF) Jul Aug (inclusive of living, child, parental leave, relocation & 3 S, PR, F I √
• Cross-Disciplinary Fellowships (CDF) research and travel allowances)
Human Frontier Science Program (HFSP) - Research Grants
• Young Investigators’ Grant Jan Mar ≤$1.35M 3 S, PR, F I √ √ √
• Program Grant
L’ORÉAL Singapore For Women In Science National Fellowship Aug Sep $30K 1 S, PR I √
Mitsui Sumitomo Insurance Welfare Foundation Research Grant May Jun ≤$10K 1 S, PR, F I √ √ √
NCID Catalyst Grant May Jun $50K 6 months S, PR, F I √ √ √
NCID Short Term Fellowship
• Incoming Fellowship Aug Sep $10K 1 week S, PR, F I √ √ √
• Outgoing Fellowship
Singapore Cancer Society (SCS)
Jul Aug ≤$200K Realistic period S, PR, F I √ √ √
• Cancer Research Grant Call
Singapore-MIT Alliance for Research and Technology (SMART) Innovation Grant Call
≤$250K (Innovation) 2 (Innovation)
• Innovation Grant Jan & Jul Mar & Dec S, PR, F I √ √ √
≤$50K (Ignition) 1 (Ignition)
• Ignition Grant
Singapore-Stanford Biodesign (SSB) Fellowship (inclusive of stipend, tuition fees & Bond duration
Apr Jun 1 S, PR, F I √ √ √
• Fellowship Program international travel support) Must work 2 years in Singapore after completion
Temasek Foundation Innovates
Singapore Millennium Foundation Grant Call (SMF) ≤$750K (Main) 3 (Main)
Nov Jan S, PR, F I, C-Inst √ √ √
• Main Grant ≤$250K (Booster) 1 (Booster)
• Booster Grant
Venerable Yen Pei-NKF
Jan & Jul Mar & Sep ≤$150K 3 S, PR I √ √
• Research Fund Grant Call
1. See NMRC’s website for salary support cap. For regular updates on new and upcoming grant calls, closing dates and other information, log on to
2. Applicants should hold a clinical qualification (e.g. MBBS, MD, BDS or equivalent), with specialty training beyond medical or dental school (including specialists, family physicians and public health practitioners).
3. For non-clinically qualified applicants working on human clinical research, such as PhD holders, exception will be made on a case-by-case basis, subject to NMRC approval. Non-medically trained PhD applicants
http://research.singhealth.com.sg or look out for the weekly SingHealth OoR e-bulletin issued
every Tuesday. LEGEND
conducting laboratory based research are not eligible. For support with grant applications or to be added to our research mailing list please contact SingHealth
4. For non-PhD and non-clinically qualified applicants, such as healthcare professionals, bio-statisticians and other holders, exception will be made on a case-by-case basis, subject to NMRC approval. Office of Research on 6576 7032 / 7014 / 7013 or office.research@singhealth.com.sg.
5. Grants open only to investigators/researchers primarily employed in SingHealth and her member institutions, unless otherwise stated. This calendar is produced by SingHealth Office of Research and is accurate as of December 2018.
A*STAR Agency for Science, Technology and Research KMRA Khoo Mentored Research Award
GRANT PRE-REVIEW TIMELINE ACP Academic Clinical Programme KPA Khoo Pilot Award
AI Artificial Intelligence KPFA Khoo Postdoctoral Fellowship Award
AM Academic Medicine LTF Long-Term Fellowships
AMC Academic Medical School MBBS Bachelor of Medicine, Bachelor of Surgery
MAY PRE-REVIEW ACADEMIC MEDICINE (AM) RESEARCH GRANT TIMELINE
NOVEMBER PRE-REVIEW AME-IRG Advanced Manufacturing and Engineering MCI Master of Clinical Investigation
NMRC: CSA, TA, CS-IRG/CS-IRG-NIG, OF-IRG/OF-YIRG, HSRG/ HSRG-NIG, CTG (ICT & IIT)
NMRC: CSA, TA, CS-IRG/CS-IRG-NIG, OF-IRG/OF-YIRG, HSRG/ HSRG-NIG, CTG (ICT & IIT) Start-up, Transition Project, Special Category - Individual Research Grant MD Doctor of Medicine
A*STAR: AME IRG/YIRG
AME-YIRG AME - Young Individual Research Grant MOH Ministry of Health
AMR Antimicrobial Resistance MSc Master of Science
BDS Bachelor of Dental Surgery MSF Medical Student Fellowship
The SingHealth Office of Research disseminates Deadline for PIs to submit Full NMRC NMRC The SingHealth Office of Research disseminates Deadline for PIs to submit Full NMRC NMRC CDF Cross-Disciplinary Fellowships NCID National Centre for Infectious Diseases
information to Institutional RDOs: proposal (through institutional information to Institutional RDOs: proposal (through institutional CIA Clinician Innovator Award
(i) Upcoming grants RDOs) to the SingHealth Office GRANT GRANT (i) Upcoming grants RDOs) to the SingHealth Office GRANT GRANT CIN Clinician-Innovator
NCSS Nurturing Clinician Scientist Scheme
NHIC National Health Innovation Centre
(ii) Requirements and deadlines for PIs’ proposals of Research for pre-review by CALL CALL (ii) Requirements and deadlines for PIs’ proposals of Research for pre-review by CALL CALL CIV Clinician-Investigator NIC National Innovation Challenge
to undergo pre-review by external parties external parties OPENS CLOSES to undergo pre-review by external parties external parties OPENS CLOSES Co-PI Co-Principal Investigator NMRC National Medical Research Council
CoSTAR-HS Collaborative Solutions Targeting Antimicrobial NKF National Kidney Foundation
Resistance Threats in Health System
NRF National Research Foundation
CRP Competitive Research Programme
NUS National University of Singapore
CS Clinician Scientist
OF-IRG Open Fund-Individual Research Grant
14 4 11 8 2 31 15 5 9 7 1 29 CSA-INV Clinician Scientist Award-Investigator
OF-LCG Open Fund-Large Collaborative Grant
CSA-SI CSA-Senior Investigator
JAN FEB MAR APR MAY MAY JUL AUG SEP OCT NOV NOV CS-IRG Clinician Scientist - Individual Research Grant
OF-YIRG Open Fund-Young Individual Research Grant
OoR Office of Research
CS-IRG-NIG CS-IRG-New Investigator Grant
PhD Doctor of Philosophy
CS/CISSP Clinician Scientist/ Clinician Investigator
PI Principal Investigator
12 16 23 Salary Support Programme
PRISM Institute of Precision Medicine
CTG-ICT Clinical Trial Grant
Deadline for PIs to submit Project Title & PIs receive pre-review (For A*STAR CSA & TA: Deadline for PIs to AUG SEP SEP PI receives pre-review CSA & TA: - Industry Collaborative Trials PULSES Population-based, Unified, Learning System
300-word Abstract (through institutional feedback from external AME grants, PI to submit via IGMS to Host Institution submit Project Title feedback from external PI to submit via IGMS for Host CTG-IIT Clinical Trial Grant
for Enhanced and Sustainable Health
RDOs) to the SingHealth Office of reviewers please refer Research Director’s & Duke-NUS Dean’s & 300-word Abstract reviewers Institution Research Director’s & - Investigator Initiated Trials R&D Research and Development
Research to identify external parties to below ) endorsements, after which application is (through institutional Duke-NUS Dean’s endorsements, FTE Full-time equivalent RDO Research Development Office
automatically routed to NMRC. RDOs) to the SingHealth after which application is HEARTS Health Services Research and Analytical SCS Singapore Cancer Society
Office of Research to GRANT Institutional RDOs’ GRANT automatically routed to NMRC. Technologies for SingHealth SGD Singapore dollar
CS-IRG/CS-IRG-NIG, OF-IRG/OF-YIRG, internal deadline HFSP Human Frontier Science Program SMART Singapore-MIT Alliance for Research and
identify external parties CALL CALL
HSRG/ HSRG-NIG, CTG (IIT): CS-IRG/CS-IRG-NIG, OF-IRG/OF- HSR Health Services Research Technology
Submit directly via IGMS to NMRC. OPENS CLOSES HSRG Health Services Research Grant SMC Singapore Medical Council
YIRG, HSRG/ HSRG-NIG, CTG (IIT):
HSRG-NIG Health Services Research SMF Singapore Millennium Foundation
CTG (ICT): Submit directly via IGMS to NMRC. - New Investigator Grant SSB Singapore-Stanford Biodesign
Submit directly via IGMS to NMRC anytime CTG (ICT): IAF-ICP Industry Alignment Fund STaR Singapore Translational Research
throughout the year. Submit directly via IGMS to NMRC - Industry Collaboration Projects Investigator Award
PRE-REVIEW (For A*STAR AME grants, please refer IAF-PP Industry Alignment Fund - Pre-positioning TA Transition Award
anytime throughout the year.
Mandatory for to below ) IGMS Integrated Grant Management System TCMRG Traditional Chinese Medicine Research Grant
i. CSA and TA I2D Innovation to Develop TDR Therapeutics Development Review
I2I Innovation to Industry USD United States dollar
ii. 1st time applicants of any competitive national grants or Pre-review is only applicable to proposals in the research areas of a) Biologics & Pharmaceutical Manufacturing and b) MedTech Manufacturing under the AME domain. Opening and closing dates are
those who have not received any competitive national grants I2Start Innovation to Startup
estimated to be in July and August based on historical information derived from A*STAR and subject to change.
before. Those who have been awarded international funding
May and November grant call closing dates are estimated from historical information derived from NMRC and subject to change.
previously will be considered on a case-by-case basis.
Optional for all othersYou can also read
